PTCT(PTC Therapeutics, Inc.) · 财务报表

PTCT(PTC Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$538.59M$698.80M$937.82M$806.78M$1.73B
毛利润—————
营业利润−$374.44M−$447.41M−$439.50M−$302.57M$866.93M
净利润−$523.90M−$559.02M−$626.60M−$363.30M$682.64M
经营现金流−$251.33M−$356.65M−$158.42M−$107.69M$711.20M
自由现金流−$279.55M−$388.67M−$186.86M−$114.19M$702.34M
摊薄每股收益$-7.43$-7.79$-8.37$-4.73$7.78

PTC Therapeutics, Inc. PTCT